SUN PHARMA INDUSTRIES LIMITED ESG Performance Analysis Report

Sun Pharma Industries Limited is one of India's leading pharmaceutical companies with a global presence across specialty medicines, generic formulations, active pharmaceutical ingredients (APIs), and healthcare solutions. This ESG Performance Analysis Report provides an independent review of the company's Environmental, Social, and Governance (ESG) disclosures and sustainability initiatives for FY 2024-25. The assessment examines environmental performance, governance effectiveness, compliance practices, social impact, stakeholder engagement, and ESG risk management. The report highlights key sustainability achievements, identifies material risks and disclosure gaps, and offers strategic recommendations to strengthen transparency, regulatory compliance, and long-term sustainable value creation.